Development Level

Tbio 3 | 10,625
Tchem 3 | 1,890

Disease

Carcinoma 5 | 2,147
osteosarcoma 4 | 7,933
psoriasis 3 | 6,685
Blastic phase chronic myeloid leukemia 2 | 58
Cancer 2 | 2,346
Chronic Myelocytic Leukemia Accelerated Phase 2 | 59
Chronic phase chronic myeloid leukemia 2 | 45
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 2 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 2 | 47
astrocytic glioma 2 | 2,241
atypical teratoid / rhabdoid tumor 2 | 4,369
breast carcinoma 2 | 1,614
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
medulloblastoma 2 | 1,524
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
ovarian cancer 2 | 8,491
pituitary cancer 2 | 1,972
primitive neuroectodermal tumor 2 | 3,031
spina bifida 2 | 1,064
Acquired metabolic disease 1 | 267
Adult T-Cell Lymphoma/Leukemia 1 | 30
Age related macular degeneration 1 | 84
Alzheimer's disease 1 | 644
Blindness 1 | 84
Breast cancer 1 | 3,098
Cherubism 1 | 14
Colorectal Neoplasms 1 | 217
Cone dystrophy 1 | 59
Congenital stationary night blindness 1 | 28
Congenital stationary night blindness, autosomal dominant 1 1 | 1
Craniofrontonasal syndrome 1 | 13
Diabetic Retinopathy 1 | 53
Fundus Albipunctatus 1 | 8
Fundus dystrophy 1 | 77
Hypertension 1 | 293
Keratomalacia 1 | 6
Keshan disease 1 | 14
Leber congenital amaurosis 1 | 72
Multiple Sclerosis 1 | 498
Night Blindness 1 | 39
Night blindness, congenital stationary 1 | 14
Night blindness, congenital stationary, autosomal dominant 1 1 | 1
Pick disease 1 | 1,893
Pigmentary retinal dystrophy 1 | 4
Placenta praevia 1 | 9
Placental insufficiency 1 | 13
Proteinuria 1 | 63
Retinal Degeneration 1 | 49
Retinal detachment 1 | 33
Retinitis 1 | 9
Retinitis Pigmentosa 1 1 | 2
Retinitis pigmentosa 1 | 156
Retinitis pigmentosa 2 1 | 2
Retinitis pigmentosa 4 1 | 1
Retinitis punctata albescens (disorder) 1 | 2
Schizophrenia 1 | 503
Uveitis 1 | 103
adrenocortical carcinoma 1 | 1,427
adult high grade glioma 1 | 2,148
aldosterone-producing adenoma 1 | 664
colon cancer 1 | 1,475
cone-rod dystrophy 1 | 60
cutaneous lupus erythematosus 1 | 1,056
ependymoma 1 | 2,514
esophageal adenocarcinoma 1 | 737
gastric carcinoma 1 | 832
glioblastoma multiforme 1 | 347
interstitial cystitis 1 | 2,299
lung adenocarcinoma 1 | 2,714
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pilocytic astrocytoma 1 | 3,086
posterior fossa group A ependymoma 1 | 1,511
subependymal giant cell astrocytoma 1 | 2,287
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 6 | 17,994
Cardiovascular System 6 | 17,957
Digestive Tract 6 | 18,472
Endocrine System 6 | 18,511
Female tissues 6 | 18,646
Liver and Pancreas 6 | 18,135
Male tissues 6 | 17,968
Nervous System 6 | 18,560
Respiratory system 6 | 17,483
Skin and soft tissues 6 | 18,114
Urinary Tract 6 | 18,443

Target Family

Non-IDG 3 | 11,969
Kinase 2 | 634
GPCR 1 | 408

Grant Application

3R01EY018207-04S1 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene vav VAV1 Tchem Non-IDG -2.64007 465.9 479
Guanine nucleotide exchange factor VAV2 VAV2 Tbio Non-IDG -1.78476 58.3 173
Ephexin-1 NGEF Tbio Non-IDG -1.15492 14.4 74
Rhodopsin RHO Tbio GPCR -3.78489 6671.2 350
Ephrin type-B receptor 1 EPHB1 Tchem Kinase -1.67313 48.2 364
Ephrin type-A receptor 1 EPHA1 Tchem Kinase -3.07839 1129.8 358